Skip to Main Content

Filter:

ISCT Publications

1 Results

Correspondence
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
Cytotherapy
Vol. 22Issue 11p602–605Published online: April 17, 2020
- Maroun Khoury
- Patricia R.M. Rocco
- Donald G. Phinney
- Mauro Krampera
- Ivan Martin
- Sowmya Viswanathan
- and others
Cited in Scopus: 26
The serious consequences of the global coronavirus disease 2019 (COVID-19) pandemic have prompted a rapid global response to develop effective therapies that can lessen disease severity in infected patients. Cell-based approaches, primarily using mesenchymal stromal cells (MSCs), have demonstrated a strong safety profile and possible efficacy in patients with acute respiratory distress syndrome (ARDS), but whether these therapies are effective for treating respiratory virus-induced ARDS is unknown.